work2play:
If the bamboo steamer and ginsu knives are included, please send me a copy.
DataMonitor is an excellent publication which covers all industries including Dnap. (Worldwide Circulation)
To continue the discussion that has been talked about on this board is the avenue Dnap is pursing. Many of you know that the FDA has politcially dragged its feet for Drug and Biotech companies.
A great example that has been developing is the drug
"Prexige", made by Novartis. It is following the same avenue
as Celebrex and Vioxx (Pharmacia and Merck-Arthritis). The one
concept that is different is the path that Novartis is taking. DataMonitor (October 21, 04) published that the drug is being used "already" in the U.K. and expanison of its product throughout Europe by 2005. By the year 2007, it hopes for FDA approval (completion of Phase III clinical trials-18 month duration). Prexige (code name 189), will be published in the American College of Rheumatology this month. I hope this shows the process drug companies for Europe. Novartis-a "Swiss" Pharmaceutical company. I like Dnap's path......
.......atkins........................
News 
Market Data 
Discover 
